Acuta Capital Erasca Bets Big on Targeted Cancer Therapies
A niche investment move places acuta capital erasca (eras) at the center of Erasca's ambitious quest in targeted canc...
If a budget falls apart, identify the breach, stop further spirals, and implement a simple recovery plan to restore stability.
16,942 articlesA niche investment move places acuta capital erasca (eras) at the center of Erasca's ambitious quest in targeted canc...
With $100 to deploy, traders face a crowded crypto menu. This article breaks down the options, highlighting the best ...
Palantir stock soared today as investors priced in a mix of solid results, new government and enterprise wins, and a ...
As volatility stays elevated, a hedge against rising option premiums is gaining attention. The 8%-yield S&P 500 Premi...
SpaceX hovers around $135 ahead of a pivotal Starship test. This report weighs the case for spacex $135: should space...
KBR faced a two-sided story: a massive backlog that hints at strong future demand, and a prominent investor trimming ...
As AI demands surge, CoreWeave positions itself as a specialized cloud provider for GPU compute. This article digs in...
A high-stakes take on the AI shift: palantir’s billionaire says only two paths will endure—master a skilled trade or ...
A long-standing storage supplier sits at the center of AI data growth. This article explains why the market may be un...
JPMorgan's JEPI ETF offers a compelling income stream through covered calls on a diversified 110-name portfolio. This...
Domo's path to 2027 earnings hinges on expanding its customer base, increasing ARR, and managing margins in a competi...
Palantir has volatile days, but one wall street analyst believes the stock could double within a year. This article b...